0.6959 0.00 (0.00%)
After hours: 6:36PM EST
China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma," the "Company" or "We"), an NYSE American-listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based in China, today announced financial results for the quarter ended September 30, 2020.
This article will reflect on the compensation paid to Zhilin Li who has served as CEO of China Pharma Holdings, Inc...
China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma," the "Company" or "We"), an NYSE American-listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based in China, today announced that the masks produced by its subsidiary Hainan Helpson Medicine & Biotechniqe Co., Ltd. has received multiple certifications, and have been listed on the Whitelist ("Whitelist" refers to the "List of Non-Medical Mask Manufacturers that have Obtained Foreign Standard Certification or Registration" and "List of Medical Material Production Enterprises that have Obtained Foreign Standard Certification or Registration" as indicated in document No. 12 issued by the Chinese government in 2020).